secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001493152-26-001898
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech furnishes January 2026 corporate presentation
------------------------------------------------------------

- Presentation filed as Exhibit 99.1 on Form 8-K dated January 12, 2026.
- No financial results or operational milestones disclosed in the filing.
- Cautionary statements reiterate risks of Ampligen development across viral, cancer, and immune indications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226001898/0001493152-26-001898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226001898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-001898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer